Premier Fund Managers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Premier Fund Managers's BMY Position: Q1 2026 in Review
Premier Fund Managers increased its Bristol-Myers Squibb (BMY) stake by 6.1% in Q1 2026, buying an estimated $758K and bringing the position to 227,500 shares worth $13.6M. The position accounts for 0.96% of the portfolio, ranked #44.
Premier Fund Managers first reported a position in BMY in Q2 2020 and has held it in 9 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Premier Fund Managers held 227,500 shares of Bristol-Myers Squibb worth $13.6M as of Q1 2026.
- Premier Fund Managers bought 13,000 Bristol-Myers Squibb shares in Q1 2026, an estimated $758K.
- Bristol-Myers Squibb made up 0.96% of Premier Fund Managers's portfolio in Q1 2026, its #44 holding.
- Premier Fund Managers first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 9 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Premier Fund Managers's 13F filing for Q1 2026, filed 14 May 2026.